You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 15, 2025

Drug Price Trends for SM CHILD ASPIRIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SM CHILD ASPIRIN

Average Pharmacy Cost for SM CHILD ASPIRIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SM CHILD ASPIRIN 81 MG CHW TAB 49348-0757-07 0.02417 EACH 2025-01-22
SM CHILD ASPIRIN 81 MG CHW TAB 49348-0757-07 0.02385 EACH 2024-12-18
SM CHILD ASPIRIN 81 MG CHW TAB 49348-0757-07 0.02289 EACH 2024-11-20
SM CHILD ASPIRIN 81 MG CHW TAB 49348-0757-07 0.02467 EACH 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Global Aspirin Market Analysis and Price Projections

Market Overview

The global aspirin market is poised for steady growth over the next few years, driven by several key factors. Here’s a comprehensive analysis of the market dynamics, price projections, and other relevant aspects.

Market Size and Growth

As of 2022, the global aspirin market was valued at approximately USD 2356.55 million and is projected to reach USD 2917.59 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of about 2.70% during the forecast period[3,.

Another report indicates that the market is expected to grow at a CAGR of 3.10% from 2023 to 2030, although the base year and forecast year values differ slightly[1].

Drivers of Market Growth

Increasing Prevalence of Cardiovascular Diseases

Cardiovascular diseases, such as heart attacks and strokes, are becoming more prevalent globally. Aspirin is widely used to treat and prevent these conditions, making it a crucial driver for market growth[1].

Technological Advancements in Drug Delivery Systems

Advancements in drug delivery systems have led to the development of aspirin formulations with controlled release, enabling once-daily dosing and potentially reducing gastrointestinal side effects. This enhances patient adherence and supports market expansion[1].

Rising Geriatric Population

The global population is aging, leading to an increase in age-related illnesses such as cardiovascular disease and arthritis. Aspirin is commonly used to treat these conditions, contributing to market growth[1].

Rising Rate of Contagious Diseases

The increasing rate of contagious diseases like the flu and cold, which often involve symptoms such as body aches and headaches, is also driving the demand for aspirin[3].

Regional Analysis

Asia-Pacific

The Asia-Pacific region is expected to dominate the aspirin market due to low costs and increased government support. Countries like China, Japan, India, and South Korea are significant contributors to this growth[1][4].

Europe

Europe is also expected to see growth, particularly due to the increasing number of cases of migraine and other cardiovascular diseases[1].

North America

In North America, the U.S., Canada, and Mexico are key markets. The region sees significant demand due to the high prevalence of cardiovascular diseases and the widespread use of aspirin for preventive measures[1].

Distribution Channels

Online and Offline Sales

The market is segmented into online and offline distribution channels. While offline channels currently hold a significant market share, online sales are growing rapidly due to increasing internet penetration and consumer preference for online retailing, especially highlighted during the COVID-19 pandemic[4].

Price Projections

Aspirin Pricing

The cost of aspirin varies based on the dosage form, quantity, and type of product. Here are some examples:

  • Oral Tablets: The cost for 100 aspirin 325 mg oral tablets can range from $10.33 to $17.80, depending on the quantity and pharmacy[2].
  • Chewable Tablets: For 36 aspirin 81 mg chewable tablets, the price can be around $9.79[2].
  • Rectal Suppositories: A pack of 12 aspirin 300 mg rectal suppositories can cost around $24.37[2].

Discounts and Assistance Programs

Consumers can benefit from discount cards and patient assistance programs, which can reduce the cost of aspirin by up to 80% at various pharmacies[2].

Challenges and Limitations

Associated Side Effects

Despite the growth drivers, the aspirin market faces challenges due to associated side effects, such as gastrointestinal issues and bleeding risks, which can restrict market growth[3].

Key Applications

Cardiovascular Disease Prevention

Aspirin is widely used for the primary prevention of cardiovascular diseases (CVD). The USPSTF recommends low-dose aspirin use for adults aged 40 to 59 years with a 10% or greater 10-year CVD risk, though the decision should be individualized[5].

Pain, Fever, and Inflammation

Aspirin is also commonly used to treat pain, fever, and inflammation, making it a staple in many households[1].

Market Players

The aspirin market includes several major players, though specific company names are not detailed in the provided sources. These companies are involved in various aspects of the market, including manufacturing, distribution, and research and development.

Conclusion

The global aspirin market is set to experience steady growth driven by increasing cardiovascular diseases, technological advancements, and a rising geriatric population. While the market faces challenges from associated side effects, the benefits of aspirin in preventing CVD and treating other conditions ensure its continued relevance.

Key Takeaways

  • Market Growth: The global aspirin market is expected to grow at a CAGR of 2.70% to 3.10% from 2023 to 2030.
  • Regional Dominance: Asia-Pacific is expected to dominate the market, followed by Europe and North America.
  • Distribution Channels: Online sales channels are growing rapidly, though offline channels still hold a significant share.
  • Price Variations: Prices vary based on dosage form, quantity, and type of product.
  • Challenges: Associated side effects and bleeding risks are significant challenges.

FAQs

1. What is the projected market size of the global aspirin market by 2030? The global aspirin market is projected to reach approximately USD 2917.59 million by 2030[3].

2. What are the main drivers of the aspirin market growth? The main drivers include the increasing prevalence of cardiovascular diseases, technological advancements in drug delivery systems, and the rising geriatric population[1].

3. How does the distribution of aspirin vary by region? Asia-Pacific is expected to dominate the market, followed by Europe and North America. The distribution channels include both online and offline sales, with online sales growing rapidly[1][4].

4. What are the common applications of aspirin? Aspirin is commonly used for the prevention of cardiovascular diseases, treatment of pain, fever, and inflammation, and other conditions such as ankylosing spondylitis[2][5].

5. Are there any discounts or assistance programs available for aspirin? Yes, consumers can benefit from discount cards and patient assistance programs that can reduce the cost of aspirin by up to 80% at various pharmacies[2].

Sources

  1. Data Bridge Market Research: Global Aspirin Market – Industry Trends and Forecast to 2030.
  2. Drugs.com: Aspirin Prices, Coupons, Copay Cards & Patient Assistance.
  3. Zion Market Research: Aspirin Market Size, Share, Value and Forecast 2030.
  4. Knowledge Sourcing: Global Aspirin Market Size & Share: Industry Report, 2022-2027.
  5. JAMA Network: Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.